Evaluation of pharmacist impact on diabetes outcomes for telehealth and hybrid care delivery versus in-office visits

BACKGROUND: Few studies have examined the effect of pharmacist-led telemanagement on diabetes outcomes during the COVID-19 pandemic. OBJECTIVES: Assess for noninferiority for the absolute change in mean A1C between telehealth and hybrid groups versus the in-office group during the COVID-19 pandemic....

Descripción completa

Detalles Bibliográficos
Autores principales: Herber, Eric, Bondar, Anna, Hockings, Jennifer, Hermiller, Taylor, Russo-Alvarez, Giavanna, Wang, Lu, Schulz, Lauren
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. on behalf of the American Pharmacists Association. 2023
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131742/
https://www.ncbi.nlm.nih.gov/pubmed/37116796
http://dx.doi.org/10.1016/j.japh.2023.04.021

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10131742/
https://www.ncbi.nlm.nih.gov/pubmed/37116796
http://dx.doi.org/10.1016/j.japh.2023.04.021

Ejemplares similares